The most prevalent tumor type was invasive carcinoma of no special type (80%) and our estrogen receptor (ER), progesterone receptor (PR), and HER2 positivity rates were 85%, 75%, and 12%, respectively. This evidence concerns the gene PGR and neoplasm.